Our qRT-PCR analysis showed that DHT treatment resulted in an increased level of SRD5A1 mRNA, whereas it led to decreased levels of SRD5A2 and SRD5A3 mRNA in LNCaP prostate cancer cells (Fig. 2A). This evidence concerns the gene SRD5A3 and prostate cancer.